peers without disabilities. 4, 5 Reduced activity and participation cause deterioration in body function and structure, such as cardiovascular disease risk, bone density, metabolic disturbance risk, obesity, and elevated blood pressures in children with CP. 6 However, many traditional physical therapies for children with CP focus on impairments within the child at the domain of body function and structure. Damiano 7 stated that "treatments cannot be justified unless they produce a change in activity, participation, or, more elusively, health-related quality of life for the person receiving the intervention." Furthermore, she stated that hippotherapy for muscle symmetry and activities is regarded as a "good" treatment approach for children with CP. Equine-assisted activities and therapies (EAATs) have been widely used as leisure activities for children with CP since the 1960s. 8 Hippotherapy was developed to maximize the therapeutic effect of EAATs. The term hippotherapy refers to how occupational therapy, physical therapy, and speechlanguage pathology for professionals use evidence-based practice, and clinical reasoning in the purposeful manipulation of equine movement to engage sensory, neuromotor, and cognitive systems to achieve functional outcomes. The three-dimensional smooth, rhythmic, and repetitive movements of the walking horse produce normalized pelvic movement similar to the pelvic movement during ambulation. 9 The warmth and rhythmic movement of the horse are estimated to decrease hypertonicity and increase range of motion. While adjusting the dynamic base of support from the horse, children can improve trunk strength, balance, and motor planning. 10 Most importantly, children with CP recognize EAATs as pleasant activities rather than therapies. Children with CP, like other children, want to be physically active, have fun, and enjoy the sensation of speed.
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EAATs have been shown to improve gross motor function, postural control, balance, 10,12 gait, 13 and functional performance 14 in children with CP. Several meta-analyses and systematic reviews have shown that EAATs positively affect gross motor function in children with CP. 10, 12, 15 Gross motor function measure (GMFM) is the most widely used outcome measure for assessing changes in gross motor function over time in children with CP. Although many studies have reported significant improvements in GMFM scores, a recent meta-analysis showed a nonsignificant increase in GMFM scores after EAATs in children with CP. 16 In fact, the improvement in the GMFM score varies widely among individuals. However, little research has been conducted on the factors that influence the gross motor outcome of EAATs in children with CP. Therefore, this study aimed to identify the individual factors influencing gross motor outcome in children with CP after hippotherapy. 
Methods

Study Design
Participants
All participants voluntarily received hippotherapy, in addition to the conventional physiotherapy that they had participated in. All participants were screened and evaluated before and after the hippotherapy by one pediatric physiatrist who had worked at a tertiary medical center located in the Seoul metropolitan. Furthermore, the medical records of all patients were reviewed by the same physiatrist. The inclusion criteria were: (1) diagnosis of CP, (2) body weight < 35 kg, and (3) age, 3 to 10 years. The exclusion criteria were: (1) botulinum toxin injection within 6 months, (2) selective dorsal rhizotomy or orthopedic surgery within 1 year, (3) moderate to severe intellectual disability (when the participant could not follow the one-step obey command), (4) uncontrolled seizure, and (5) poor visual or hearing acuity. These criteria have been used for selecting participants in our center since 2008. Participants who were absent for the lessons more than four times were excluded from the final analysis. All the parents agreed on behalf of the participants to refrain from botulinum toxin injection during the course of the therapy. included muscle relaxation; sustenance of optimal postural alignment of the head, trunk, and lower extremities and independent sitting; and active exercises (stretching, strengthening, dynamic balance, and postural control) directed by the therapist. The participants were encouraged to maintain postural alignment during all the activities. The intensity of the exercises and degree of assistance were individualized according to the participants' ability to control their posture.
Ethics
The study protocol was reviewed and approved by the institutional review board at the Samsung Medical Center (registry no. SMC 2017-12-081). Informed consent was waived due to the retrospective nature of the study.
Outcomes Measured
Primary Outcome: GMFM-66
Assessment of GMFM-66 was performed by two pediatric physical therapists before and after the 8-week hippotherapy program. The change in GMFM-66 is a reliable tool for detecting changes in gross motor function in children with CP.
17 GMFM-66 consists of 66 items through Rasch's analysis, excluding 22 items with repeated difficulty levels.
Secondary Outcome: GMFM-88
The GMFM-88 consists of 88 items in the following five dimensions: (A) lying and rolling; (B) sitting; (C) crawling and kneeling; (D) standing; and (E) walking, running, and jumping.
17
Secondary Outcome: PBS
The PBS is a modified version of the Berg's balance scale and used in children with spastic CP. The PBS consists of 14 items and evaluates functional balance in everyday tasks. The items assess the functional activities within the home, school, or community, including sitting balance, standing balance, sit to stand, stand to sit, transfers, stepping, reaching forward, reaching the floor, turning, and stepping on and off through an elevated surface. Each item is scored on a four-point scale.
The validity and inter-/intrarater reliability of PBS have been demonstrated in children with CP.
20
Statistical Analysis
We regarded children with an increase in GMFM-66 of 2.0 points as good responders to hippotherapy as mentioned above. The variables used for univariate logistic regression were age, sex, distribution, CP type, GMFCS level, baseline GMFM A/B/C/D/E, and baseline PBS. For analysis purposes, GMFCS levels were stratified into three groups, namely, levels I and II, III, and IV. The possibility of self-ambulation and the necessity of using walking aids are the most important factors in classifying children with CP according to their motor function. Baseline GMFM-66 and baseline GMFM-88 were strongly correlated with each other. Therefore, baseline GMFM-88 was excluded from the selection of variables.
Variables with p-values less than 0.2 in the univariate logistic regression analysis were selected for multivariate logistic regression analysis to identify the factors that affected the efficacy of hippotherapy. The significance level was set at < 0.05. All analyses were performed with SPSS version 24.0 software (IBM Corp., Armonk, New York, U.S.A.).
Results
We enrolled 155 participants who met the inclusion and exclusion criteria. Nine children were excluded from the final analysis owing to frequent absences (> four times). Finally, the data of 146 participants were analyzed retrospectively. The attendance rate of the participants was 94.0 AE 8.0%.
The mean age of the participants was 5.78 AE 1.72 years. Of the 146 participants, 82 (56.2%) were boys; 128 (87.7%), 10 (6.8%), and eight (5.5%) participants were spastic, dyskinetic, and ataxic CP, respectively. Of the 128 children with spastic CP, 12 had a unilateral distribution; 24 (16.4%), 48 (32.9%), 44 (30.1%), and 30 (20.5%) participants were GMFCS levels I and II, III and IV (►Table 1), respectively.
Seventy-one participants (48.6%) were good responders to hippotherapy. There was no difference in the proportion of good responder in sex, age, CP type and distribution subgroups. However, as a result of linear-by-linear association analysis, we found that as the GMFCS level increased, the proportion of good responder decreased (►Table 1).
GMFM-88 changes in children with unilateral CP were significantly greater than in those with bilateral CP (p ¼ 0.001). There was no statistical difference of GMFM-66, GMFM-88 and PBS changes according to CP types. There were significant differences in GMFM-66, GMFM-88, and PBS changes according to the GMFCS level. Results are described in detail in ►Table 2.
Variables with p-values less than 0.2 in the univariate logistic regression analysis were: the GMFCS level; the baseline GMFM B, C, D, and E scores; and the baseline PBS score. In the multivariate logistic regression analysis, GMFCS level of I and II compared with IV (p ¼ 0.046) and III compared with IV (p ¼ 0.045), baseline GMFM E score (p ¼ 0.031), were the factors that had a positive influence on good response to hippotherapy. Baseline GMFM B score (p ¼ 0.046) had a negative influence on good response to hippotherapy. Sex, age, CP type and distribution were not factors influencing gross motor outcome of hippotherapy according to our analysis (►Table 3).
Discussion
Here, we found that the children with CP, GMFCS levels I and II or III, with relatively poor postural control in sitting might have a greater chance to improve their GMFM-66 scores through hippotherapy. To our knowledge, this study is the first to analyze the factors that affect the therapeutic effect of hippotherapy. Conflicting evidence exists regarding the improvement of GMFM scores after hippotherapy. Despite this, many studies reported significant improvements: the most recent meta-analysis revealed an insignificant increase in GMFM score. 16 Contributing to these contradictory results may be the limitations of small sample sizes, individual variability (gross motor functions, age, and CP types and distribution), types of intervention (hippotherapy vs. therapeutic horseback riding and private lesson vs. group lesson), and insufficient intervention duration. This study involves a relatively large number of subjects (146 participants with CP). Furthermore, the intervention is relatively uniform over a sufficient period (single-center study for 8 weeks). As we also had observed that the degree of improvement in GMFM scores after hippotherapy had individual differences, we would like to analyze factors (individual variables) that affect the gross motor outcome measured using GMFM-66. As the minimal clinically important difference in GMFM-66 was reported to be 1.58, we regarded the children with GMFM-66 scores increased by 2.0 points as good responders to hippotherapy. Moreover, we analyzed the factors that affected good responders. Several studies have been conducted that investigate the factors are affecting the response of children with CP to physical therapy in a hospital setting. Chen et al reported that the PT efficacy of young (< 3 years old) children with CP was better and that the GMFM-66 score improved at 8 years of age. Furthermore, the improvement differed among the five GMFCS levels (p < 0.001), and GMFCS level II had a faster progression in Chen et al's study. 20 Similar results were confirmed in another study on factors that affected the response to intensive therapy in children with CP or developmental delay. 21 However, we could not find any additional effects of age on GMFM improvement after hippotherapy, which is not consistent with previous studies. 20, 21 This result is thought to be due to the fact that approximately half of the participants were aged 6 years or older who already reached the plateau of the GMFM-66 score. This can be paradoxically interpreted that hippotherapy can be an effective therapy for some school-aged children with little potential of further improvement in GMFM scores. Like conventional PT, hippotherapy was more effective in the ambulatory group than in the nonambulatory group. The participants with GMFCS levels I and II and III were significantly more likely to be good responders than those with GMFCS level IV (►Table 3, odds ratio [OR] ¼ 6.83, 4.45). The most marked change in GMFM-88 was noted in GMFCS level III and the most marked change of PBS was noted in GMFCS level II. A recent study that used ICF-CY checklist confirmed that the effect of hippotherapy was distinct from GMFCS levels, and most improvements were present in children with GMFCS levels I-III.
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The GMFM-66 curves appear to reach plateaus by about age 7 years. Children, on average, reach approximately 90% of their motor function (as measured by the GMFM-66) by around age 5 years, depending on their GMFCS level. Children with GMFCS levels IV and V are expected to achieve 90% of their potential GMFM score at the age of 3.5 and 2.7 years, respectively. 23 Children with GMFCS levels IV and V exhibited significant limited motor function and potential to improve. 24 However, this does not mean that hippotherapy should be performed only for children with GMFCS levels I and II, or III. The previous randomized controlled trial (RCT) study showed that the gross motor function of children with GMFCS level IV was also significantly improved as compared with that of the control group after hippotherapy. 25 Hsieh et al reported that the limitations of activities and participation domain of the ICF-CY checklist (d235-managing one's behavior, and d315-communicating with or receiving nonverbal messages) were reduced after hippotherapy in children with GMFCS levels IV and V. They thought that this improvement may have been due to an increased awareness of the child's ability to communicate and perform general tasks and respond to demands. The authors stated that hippotherapy may provide these children with a modifying activity that ensures their participation in building a relationship with a horse.
The GMFM D and E areas have a decisive impact on the GMFM-66 score. All 13 GMFM-88 D items and all 24 GMFM-88 E items are included in GMFM-66. Therefore, high GMFM D and E scores can affect further improvement in GMFM-66 score. We found that baseline GMFM E score (walking, running, and jumping) was a positive predictive factor of hippotherapy. However, unexpectedly, we found that a lower B score (a low sitting function) predicts a better outcome of hippotherapy. During hippotherapy, children do various activities to improve postural control in the sitting position. Previous meta-analysis studies demonstrated that EAATs are indicated to improve postural control and balance in children with CP.
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The present results and previous meta-analysis results suggest that hippotherapy is a context-focused therapy to improve postural control in sitting. Children with CP and GMFCS levels I and II or III who have relatively poor postural control in sitting might have a greater chance to improve their GMFM-66 scores through hippotherapy. This result also supports the recent study which suggests that hippotherapy shows distinct therapeutic strengths with regard to promoting upright stand and gait in children with cerebral palsy. 26 We did not find any influence of CP type and distribution on the increase in GMFM-66 score after hippotherapy. Relatively fewer ataxic (5.5%) and dyskinetic (6.8%) CP cases than spastic cases were enrolled in this study. Spastic CP is the most common type of CP, accounting for 72 to 91% of CP cases.
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Furthermore, children with dyskinetic CP were reported to have more severe cognitive and motor impairments than children with bilateral spastic CP.
28 Therefore, they were likely to have been excluded from the therapy according to our inclusion/ exclusion criteria. There is a big difference in gross motor function between the children with unilateral CP and those with bilateral CP; 98% of hemiplegia, 66.7% of diplegia, and only 3.9% of quadriplegia were reported as GMFCS levels I-II. 29 The greater change of GMFM-88 in unilateral CP might be attributed to the high percentage of GMFCS levels I and II in this group. Children's participation in activities at home, school, and community is one of the most important outcomes of rehabilitation interventions, because it is fundamental to their health and development. Most traditional interventions for children with CP focus primarily on factors in the domain of body function and structure. EAATs seem to be attractive to all children with CP and their family members, as it is a fun sport that improves their body functions, activities, and participation. 22 Emerging therapy interventions for children with physical disabilities suggest focusing changes in the environment and/or the activity demands (i.e., context-focused therapy) rather than on directing change to the child's abilities (i.e., child-focused therapy) as a useful approach to improve function and participation.
30
Furthermore, the recently introduced treatment models influenced by the dynamic systems theory consider task or activity completion as the goal, with less emphasis on remediation or "normalization" of movement components.
31
From this point of view, EAATs can be a context-focused, goal-based therapy for children with CP. During hippotherapy, the rider must perform various activities and tasks on the horse in real-life environments outside the therapy gym (barn, arena, nature, etc.). Moreover, human-horse interaction is a powerful motivation for engaging children's participation in the therapy. 32 Novak stressed the importance of "child-active approaches" where the child is actively practicing real-life tasks during intervention (usually in real-life environments) to gain or consolidate real-life skills that they want to learn.
33
Limitations
This study has several limitations. First, this is a retrospective study without a control group. A prospective RCT should be conducted to confirm our results. Our results indicate that walking ability is a determinant factor influencing motor outcome of hippotherapy in children with CP. Therefore, in designing future studies, the GMFCS level of children should be considered as an inclusion/exclusion criterion. Hippotherapy is currently classified as a yellow-light intervention which had either lower-level evidence supporting their effectiveness or inconclusive evidence. Novak stated that "when yellow-light interventions are used, it is imperative that clinicians utilize a sufficiently sensitive outcome measure to confirm whether or not the intervention is working and if it is helping the child to achieve their family's goals." 33 From this point of view, the Canadian occupational performance measure and goal attainment scaling (GAS) are recommended as outcome measures in EAATs or hippotherapy research. Both measures work well within a family-centered approach because they encourage family-led goal setting and facilitate individualization that is critical to heterogeneous conditions, such as CP. The therapeutic riding assessment of impact network proposed using GAS as a common outcome measure at four therapeutic riding When planning EAAT or hippotherapy clinical trials, we recommend standardized outcome measures that meet corresponding individual's goals based on the ICF model (body structure/function, activity, and participation). The complexity of EAATs or hippotherapy has an important influence on RCT design. The key issues to consider include the definition of each intervention and their components, the person providing the intervention (therapists, instructors, and side-walkers), and where and how the interventions will be standardized and monitored during the trial. Second, the proportion of children significantly differed with CP type. Supplementing the proportion of children with ataxic/dyskinetic CP and hemiplegic CP may enable further analysis. Third, factors related to the longterm effects of hippotherapy remain unknown. Furthermore, this retrospective study did not clarify the effects of the individual language ability, cognitive level, and attention on GMFM improvement after hippotherapy. Fourth, the examiners were not blind to the intervention and therefore, the postintervention ratings could have a positive bias.
